Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis

NCT02536404 is registered in ClinicalTrials.gov with Arena Pharmaceuticals as lead sponsor.

NCT NCT02536404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02536404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Lead sponsor
Arena Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
January 25, 2016
Completion date
November 1, 2018
Enrollment
118 (actual)
Sites
127

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis